Daniel Rueda
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
-
- Genetic factors in colorectal cancer
Papers in
-
- Genetic factors in colorectal cancer 30
-
- Cannabis and Cannabinoid Research 8
- Co-authors
- Ismael Galve‐Roperh (8 shared papers)Manuel Guzmán (8 shared papers)Cristina Sánchez (3 shared papers)Guillermo Velasco (3 shared papers)Teresa Gómez del Pulgar (2 shared papers)Alberto Martı́nez-Serrano (1 shared paper)Amador Haro (1 shared paper)Margot Thome (3 shared papers)
- Journals
- Molecular Pharmacology (4 papers)Gastroenterology (3 papers)Clinical Genetics (2 papers)British Journal of Cancer (2 papers)Scientific Reports (2 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Daniel Rueda
56 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 76
- Pharmacology 1.2k
- Pathology and Forensic Medicine 484
- Cancer Research 282
- Developmental Neuroscience 42
- Oncology 208
Countries citing papers authored by Daniel Rueda
This map shows the geographic impact of Daniel Rueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rueda more than expected).
Fields of papers citing papers by Daniel Rueda
This network shows the impact of papers produced by Daniel Rueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rueda. The network helps show where Daniel Rueda may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Rueda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. | 2001 | 382 |
| 2 | 2008 | 261 | |
| 3 | 2002 | 216 | |
| 4 | 2000 | 173 | |
| 5 | 2002 | 166 | |
| 6 | 1998 | 164 | |
| 7 | 1999 | 147 | |
| 8 | 2021 | 106 | |
| 9 | 2015 | 90 | |
| 10 | 2001 | 88 | |
| 11 | 2006 | 77 | |
| 12 | 2013 | 73 | |
| 13 | 2007 | 42 | |
| 14 | 2019 | 42 | |
| 15 | 2005 | 35 | |
| 16 | 2017 | 31 | |
| 17 | 2015 | 28 | |
| 18 | 2019 | 28 | |
| 19 | 2019 | 28 | |
| 20 | 2022 | 25 |
About Daniel Rueda
Daniel Rueda is a scholar working on Pathology and Forensic Medicine, Pharmacology, Cancer Research, Oncology and Genetics, having authored 56 papers that have together received 2.6k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (30 papers), Cannabis and Cannabinoid Research (8 papers), NF-κB Signaling Pathways (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Colorectal Cancer Screening and Detection (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Pharmacology (1.2k citations), Pathology and Forensic Medicine (484 citations), Cancer Research (282 citations), Developmental Neuroscience (42 citations) and Oncology (208 citations). Daniel Rueda has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Ismael Galve‐Roperh, Manuel Guzmán, Cristina Sánchez, Guillermo Velasco, Teresa Gómez del Pulgar, Alberto Martı́nez-Serrano, Amador Haro, Margot Thome, César Corbacho and Maria L. DE CEBALLOS. Their work appears in journals such as Molecular Pharmacology, Gastroenterology, Clinical Genetics, British Journal of Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.